Lower Limb neurological examination |OSCE

June 18, 2014 by mediconepal

OSCE Guide for the neurological examination of lower limb video
watch here

The truth about alcohol. 15 Things You Should Know about Alcohol.
by bibek bhatta
Alcohol or ethanol or ethyl alcohol is an ingredient that is found in wine, beer, or spirits. Alcohol is a ‘sedative hypnotic’ drug. This means it depresses the central nervous system at high doses. Here in this article, I will outline the truth about alcohol Why do people drink alcohol? There are various reasons why ... Read more
XIVth National Conference of the Society of Surgeons of Nepal in Collaboration with SAARC Surgical Care Society
by medico
About the conference The Society of Surgeons of Nepal (SSN) is an esteemed, professional, and non-profit organization dedicated to the community of surgeons in Nepal. Established in June 1992, SSN operates as a Non-Government Organization (NGO) and is officially registered with the Kathmandu district administration office. The primary mission of SSN is to create ... Read more
MediCoSpace: Visual Decision-Support for Doctor-Patient Consultations using Medical Concept Spaces from EHRs
by Recent Advance
Abstract Healthcare systems are under pressure from an aging population, rising costs, and increasingly complex conditions and treatments. Although data are determined to play a bigger role in how doctors diagnose and prescribe treatments, they struggle due to a lack of time and an abundance of structured and unstructured information. To address this challenge, we ... Read more
postpartum psychosis
by medicare nepal
Some women will experience a particularly severe form of postpartum mental illness called postpartum psychosis, which typically starts suddenly and very soon after childbirth, usually within the first few days or weeks. This is much rarer than postpartum depression, affecting around 1-2 of every 1000 new mothers (0.1-0.2%). The symptoms of postpartum psychosis are varied ... Read more
HER2-Positive Breast Cancer Treatment
by medicare nepal
The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved to be used to prevent a relapse in patients with early-stage HER2-positive breast cancer. Pertuzumab (Perjeta) is used to treat metastatic HER2-positive breast cancer, and also both before surgery (neoadjuvant) and after surgery (adjuvant therapy). Trastuzumab and pertuzumab together can be used ... Read more